News Image

Which S&P500 stocks are moving on Monday?

By Mill Chart

Last update: Nov 28, 2022

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Today's top gainers

TickerChangeComment
WYNN3.6%WYNN RESORTS LTD's (NASDAQ:WYNN) shares rose 3.6% to $77.63 during Monday's session. In the last month the stock gained 34.31%.
TSLA2.49%TESLA INC's (NASDAQ:TSLA) shares rose 2.49% to $187.42. In the last 3 months the stock lost 36.53%.
ULTA2.23%ULTA BEAUTY INC's (NASDAQ:ULTA) shares rose 2.23% to $458.36 during Monday's session. Today NASDAQ:ULTA is releasing earnings.
CTLT1.91%CATALENT INC (NYSE:CTLT) rose 1.91% to $42.18 during Monday's after hours session. The stock is trading 37.54% lower than a month ago.
VRTX1.8%VERTEX PHARMACEUTICALS INC's (NASDAQ:VRTX) stock price increased by 1.8% to $318.61. Shareholders saw the stock price going 70.48% higher is the past year.
ATVI1.59%ACTIVISION BLIZZARD INC's (NASDAQ:ATVI) shares rose 1.59% to $74.64. Shareholders saw the stock price going 21.2% higher is the past year.
AMZN1.38%AMAZON.COM INC's (NASDAQ:AMZN) stock price is advancing with 1.38% to a price of $94.7. Shareholders saw the stock price going 28.56% lower in the past 3 months.
REGN1.37%REGENERON PHARMACEUTICALS (NASDAQ:REGN) rose 1.37% to $746.34 during Monday's after hours session. In the last 3 months the share price increased with 23.49%.
LYV1.34%LIVE NATION ENTERTAINMENT IN's (NYSE:LYV) shares rose 1.34% to $69.38. In the last 3 months the share price dropped with 25.42%.
BBY1.24%BEST BUY CO INC's (NYSE:BBY) stock price increased by 1.24% to $82.24. Yesterday the company had a press release: Best Buy Proves Brick and Mortar is Here to Stay.

Our top gainers screener will show you the full list.

Losers

TickerChangeComment
BIIB-4.78%BIOGEN INC's (NASDAQ:BIIB) shares fell 4.78% to $290.57 during Monday's session. Shareholders saw the stock price going 53.66% higher in the past 3 months.
LUMN-4.54%LUMEN TECHNOLOGIES INC's (NYSE:LUMN) shares fell 4.54% to $5.58. In the last 3 months the stock lost 45.72%.
TDG-4.24%TRANSDIGM GROUP INC's (NYSE:TDG) shares fell 4.24% to $609.54.
MDT-3.96%MEDTRONIC PLC's (NYSE:MDT) shares fell 3.96% to $75.98 during Monday's session. In the last 6 months the stock lost 20.15%.
EFX-3.96%EQUIFAX INC's (NYSE:EFX) shares fell 3.96% to $192.5. In the last month the stock gained 20.34%.
STT-3.88%STATE STREET CORP's (NYSE:STT) shares fell 3.88% to $74.07.
STX-3.73%SEAGATE TECHNOLOGY HOLDINGS's (NASDAQ:STX) shares fell 3.73% to $52.66 during Monday's session. In the last 3 months the share price dropped with 26.7%.
MU-3.51%MICRON TECHNOLOGY INC's (NASDAQ:MU) shares fell 3.51% to $56.36 during Monday's session. In the last 6 months the share price dropped with 20.34%.
GNRC-3.26%GENERAC HOLDINGS INC's (NYSE:GNRC) shares fell 3.26% to $101.82. In the last 3 months the share price dropped with 55.19%.
WDC-3.21%WESTERN DIGITAL CORP's (NASDAQ:WDC) stock price decreased by 3.21% to $36.14. The stock is trading 40.02% lower than 6 months ago.

To see the full list of top losers you can use our top losers screener.

Back

REGENERON PHARMACEUTICALS

NASDAQ:REGN (4/24/2024, 10:37:14 AM)

910.55

+3.23 (+0.36%)

REGN News

News Image2 hours ago - Regeneron Pharmaceuticals, Inc.Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
News Image2 hours ago - Regeneron Pharmaceuticals, Inc.Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO

Oral presentation will feature new data for investigational REGN7075, an EGFRxCD28 costimulatory bispecific with the potential to enhance the treatment of...

News Image3 hours ago - The Motley Fool2 Small-Cap Growth Stocks With Room To Run

These two small-cap growth stocks could be ready to run.

News Imagea day ago - Market News VideoNoteworthy Tuesday Option Activity: NUE, PNC, REGN
News Image2 days ago - Regeneron Pharmaceuticals, Inc.Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
News Image2 days ago - Regeneron Pharmaceuticals, Inc.Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)

Oral presentations include updated results from clinical study of otoferlin gene therapy DB-OTO demonstrating restoration in children with profound genetic...

News Image6 days ago - Kirby McInerney LLPKirby McInerney LLP Announces Investigation of Shareholder Claims Against Regeneron Pharmaceuticals, Inc. (REGN)
News Image7 days ago - Bragar Eagel & SquireREGENERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Regeneron Pharmaceuticals, Inc. on Behalf of Regeneron Stockholders and Encourages Investors to Contact the Firm
News Image7 days ago - Law Offices of Frank R. CruzThe Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors
News Image12 days ago - Investor's Business DailyStock Market Sends Mixed Signals; Nvidia, Inflation, Mideast Fears In Focus: Weekly Review

The stock market gave some bullish signs, with Nvidia rebounding, but the indexes generally fell for the week on inflation and Mideast fears.

News Image13 days ago - Schall LawINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
News Image13 days ago - Investor's Business DailyAre Regeneron's Legal Troubles — And Six-Week Slide — A Buying Opportunity?

Regeneron has fallen more than 6% over the past six weeks, and dropped again Thursday, as the DOJ focuses on its Eylea franchise.

REGN Links
Follow us for more